TrialAmyotrophic lateral sclerosis & frontotemporal degeneration2014

Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients.

Koji Abe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.